University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 70852, Czechia
NCT Number: NCT06573827
The presented project aims to characterize the microbiome of healthy peri- and postmenopausal women and its correlation with the metabolome of urine and serum.
Trial opening soon.
Get Notified50 year and older
Female
Observational
Ostrava, Moravian-Silesian Region, 70852, Czechia
At the beginning of their visit to the Blood Center of the University Hospital Ostrava, blood and plasma donors will be approached by one of the authorized members of the team with information about the possibility of participating in this study. The course of the study will be explained to them in detail, including the sampling methodology, their processing, and further handling. If the subject is interested in participating in the study, they will give written informed consent to participate in the study. Subsequently, the inclusion and exclusion criteria for participation in the study will be verified. If these are not met, the subject will be excluded from the study. Furthermore, the criteria for current valid blood and urine sampling will be verified. If the conditions for valid sampling are not met and the participant is still interested in participating in the study, she will be offered a new sampling date. If the study subject fulfills the conditions of valid sampling, she will fill out a simple questionnaire, which will be used to obtain data on basic demographic characteristics. Their knowledge is essential for the correct interpretation of urine and serum test results. Blood and serum will then be collected. In justified cases, sampling can also be carried out at the Urology Department of the University Hospital Ostrava. After submitting the first sample, the participant will be asked to submit another urine and serum sample in 3-6 months. By submitting the 2nd urine and serum sample, the participant ends her participation in the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood and urine sample evaluation will be performed in healthy female volunteers.
Time frame: 6 months
The number of bacterial species in the urine sample will be assessed.
Time frame: 6 months
Inter-individual variability in the proportion of bacterial species will be assessed.
Time frame: 6 months
The correlation of microbiome alpha-diversity and serum metabolome will be assessed.
Trial opening soon.
Get NotifiedUniversity Hospital Ostrava
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07645235
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT07555964
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Angers, France
View Trial DetailsNCT07371429
Bacterial Infections, Bacterial Infections and Mycoses
View Trial DetailsNCT07507851
Disease Attributes, Electroacupuncture
Beijing, China
View Trial Details